Brief: Nanoviricides - On Jan 24, 2020, Entered Into Settlement Agreement & Mutual Release With Investors To Securities Purchase Agreement Dated Feb 27, 2019
28/01/2020 11:38
Jan 28 (Reuters) - NanoViricides Inc NNVC.A :
* NANOVIRICIDES - ON JAN 24, 2020, ENTERED INTO SETTLEMENT
AGREEMENT & MUTUAL RELEASE WITH INVESTORS TO SECURITIES PURCHASE
AGREEMENT DATED FEB 27, 2019
* NANOVIRICIDES - AGREEMENT TO SETTLE ACTION COMMENCED BY
INVESTORS TO ENJOIN CO'S PREVIOUSLY DISCLOSED UNDERWRITTEN
PUBLIC OFFERING - SEC FILING
Source text: (http://bit.ly/2S8IL0L)
Further company coverage: NNVC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NanoViricides,
See all newsExplainer: What do we know about the Bundibugyo strain of the Ebola virus?
Brief: anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and Measles
Brief: Nanoviricides Says NV-387 Shows Activity Against Measles Virus In Humanized Animal Model
Brief: Nanoviricides Co's Business Not Affected By Tariff Policies Of Us Government Or Corresponding Retaliatory Policies Of Other Governments
Brief: Nanoviricides Obtained Right Of First Refusal For All Antiviral Drug Developments